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Abstract
Antibiotic resistance in bacteria has become a rising problem
since the first antibiotic was created, further aggravated by the
improper overuse to treat common infections. Because of this
pharmaceutical companies must keep making new and stronger
antibiotics. Surfactants are plentiful and effective killers of many
surface bacteria and are also varied in their structure. All have a
hydrophilic head and long hydrophobic carbon chain. These long
hydrophobic carbon chains can pierce through the lipid bilayers
that make up bacteria cell membranes and cause cytoplasmic
leakage and lysis of the cell wall, leading to cell death. One
proposed surfactant is synthesized by taking N-benzylamino
ethanol dissolved in absolute ethanol and adding 1bromododecane in excess then left to reflux. Mesoporous silica
nanoparticles, or MSNs, are versatile drug delivery vessels that
can uptake a variety of drugs in simple one pot synthesis. The
desired drug is dissolved in a typically basic solvent at critical
micelle concentration, then Tetraethyl orthosilicate (TEOS) is
added and the reaction is allowed to reflux until a precipitate is
formed. The MSN can then be further functionalized with a
gatekeeper to help target bacteria and force the loaded drug inside
the MSN to be released when desired. In this case a peptide chain
with Vancomycin attached to the end will be used to
functionalize the MSNs. Both the synthesized surfactants and the
loaded MSNs are tested against the model pathogen Micrococcus
luteus to test for their effectiveness in killing bacteria. In future
work MSNs loaded with various surfactants will be synthesized
and possible use of different bulky gatekeepers to functionalize
the outside of MSNs will be considered.
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Conclusion

Using solid phase synthesis the following peptide was made:
Vancomycin-GSGLAG-LVGPAG-LAGAGSG
Vancomycin was attached just like any other amino acid or florescent dye
to the N-terminus end.
➢ It was mixed with HBTU in a 1:2.9 ratio by molecular weight.
➢ Dissolved in a solvent mixture of DIEA and DMF in a1:29 ratio by
volume.
➢ Left to spin with Peptide chain for a full 24 hours.
The completed peptide chain then has its protective resin group cleaved
off to prepare for attachment to surfactant loaded MSN.

https://www.antibodies-online.com/resources/17/5034/peptidesynthesis-methods-and-reagents/
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Future Work
Reflux @ 85˚C
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➢ Surfactant SB12 at critical micelle concentration and 350µL 2M NaOH dissolved in water.
➢ 700µL TEOS and +100mg APTES mixed and added to solution slowly dropwise to avoid aggregation.
➢ Stirred and refluxed at 85ºC overnight.

Reflux @ 90ºC

Absolute Ethanol
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SB12

1-Bromododecane, 1,12-Dibromododecane, and NBenzylethanolamine in 2:1:2 ratio dissolved in absolute
ethanol and left to reflux at 90º C for 48 hours

➢ Surfactant SB12 is a deadly antibiotic that kills by
disrupting the cellular membrane lipid bilayer causing
cytoplasmic leakage.
➢ The MSNs made in our lab are made using a simple
one pot synthesis.
➢ The drug loaded into the MSN can be almost anything
theoretically.
➢ The MSN is functionalized with a peptide chain
connected to a large, bulky antibiotic.
➢ Peptide chain acts as a targeting system. Cleaving
itself around certain enzymes found around
infection sites and releasing the gatekeeper and
therefore releasing the surfactant loaded into the
MSN.
➢ Vancomycin acts as a gatekeeper, sterically
blocking SB12 from being released, to control drug
emission rate of SB12 loaded in the MSN.
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➢ Characterization of SB12 loaded MSN using DLS and
TGA
➢ Cell studies with model pathogen Micrococcus luteus
➢ Studies with unaltered peptide functionalized surfactant
MSN to show that gatekeeper works and isn’t allowing
SB12 to be released
➢ Studies with enzymes to show that peptide will cleave
properly to allow the release of SB12
➢ Functionalize MSN with different peptide sequences
➢ Load MSN with different surfactant
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The surfactant MSN is treated like an amino acid in solid phase peptide synthesis, attaching one of the various amine
groups of the MSN to the C-terminus tail of the peptide chain.
➢ The surfactant MSN is mixed with HBTU in a 1:2.9 ratio by molecular weight.
➢ This mixture is dissolved in a solution of DIEA and DMF in a 1:29 ratio by volume.
➢ The dissolved MSN and HBTU is then swirled with the peptide for 24 hours.
The end product theoretically results in a MSN with a peptide chains attached to each amine groups on the surface of
the MSN.
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